Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Frontiers in Genetics|September 16, 2024
Human sulfotransferase SULT2B1 physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditionsFatemah A AlherzJournal of Infection and Public Health|March 23, 2024
Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi ArabiaFatemah A Alherz, Amjaad A Alamri, Aseel Aljbreen, et al.Frontiers in Pharmacology|May 16, 2025
Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi populationMohammad A Alshabeeb, Deemah Alwadaani, Sireen A R Shilbayeh, et al.Canadian Journal of Physiology and Pharmacology|February 9, 2017
A reappraisal of the 6-O-desmethylnaproxen-sulfating activity of the human cytosolic sulfotransferasesFatemah A Alherz, Daniyah A Almarghalani, Noor A Hussein, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 21, 2023
Potential cardioprotective effects of Amentoflavone in doxorubicin-induced cardiotoxicity in miceFatemah A Alherz, Thanaa A El-Masry, Walaa A Negm, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2023
The potential beneficial role of Ginkgetin in doxorubicin-induced hepatotoxicity: Elucidating the underlying claimFatemah A Alherz, Walaa A Negm, Thanaa A El-Masry, et al.Chinese Journal of Integrative Medicine|September 19, 2024
Hepatoprotective Effect of Camel Thorn Polyphenols in Concanavalin A-Induced Hepatitis in MiceNageh Ahmed El-Mahdy, Thanaa Ahmed El-Masry, Ahmed Mahmoud El-Tarahony, et al.The Journal of Pharmacy and Pharmacology|September 8, 2024
Shikonin mitigates cyclophosphamide-induced cardiotoxicity in mice: the role of sirtuin-1, NLRP3 inflammasome, autophagy, and apoptosisFatemah A Alherz, Asmaa Saleh, Mona Y Alsheikh, et al.Journal of Fungi (Basel, Switzerland)|October 27, 2022
Silver Nanoparticles Prepared Using Encephalartos laurentianus De Wild Leaf Extract Have Inhibitory Activity against Candida albicans Clinical IsolatesFatemah A Alherz, Walaa A Negm, Engy Elekhnawy, et al.Pharmaceuticals (Basel, Switzerland)|January 6, 2026
RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527Thanaa A El-Masry, Maysa M F El-Nagar, Nageh A El Mahdy, et al.Pageof 3